Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The three EglN prolyl hydroxylases (EglN1, EglN2, and EglN3) regulate the stability of the HIF transcription factor. We recently showed that loss of EglN2, however, also leads to down-regulation of Cyclin D1 and decreased cell proliferation in a HIF-independent manner. Here we report that EglN2 can hydroxylate FOXO3a on two specific prolyl residues in vitro and in vivo. Hydroxylation of these sites prevents the binding of USP9x deubiquitinase, thereby promoting the proteasomal degradation of FOXO3a. FOXO transcription factors can repress Cyclin D1 transcription. Failure to hydroxylate FOXO3a promotes its accumulation in cells, which in turn suppresses Cyclin D1 expression. These findings provide new insights into post-transcriptional control of FOXO3a and provide a new avenue for pharmacologically altering Cyclin D1 activity.

Original publication

DOI

10.1101/gad.242131.114

Type

Journal article

Journal

Genes Dev

Publication Date

01/07/2014

Volume

28

Pages

1429 - 1444

Keywords

Cyclin D1, EglN2, FOXO3a, USP9x, breast cancer, prolyl hydroxylation, Animals, Cell Line, Cells, Cultured, Cyclin D1, Forkhead Box Protein O3, Forkhead Transcription Factors, Gene Expression Regulation, Neoplastic, Hydroxylation, Hypoxia-Inducible Factor-Proline Dioxygenases, MCF-7 Cells, Mice, Protein Binding, Protein Stability, Ubiquitin Thiolesterase